Clinical Trial Update: Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of TissueGene-C mixed with fibrin glue for degenerative arthritis has been completed. The sponsor summarizes th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Arthritis

Drugs mentioned

• TissueGene-C (TG-C)

Snippet

Sponsor: Kolon Life Science | Conditions: Degenerative Arthritis | Phase 2 | Status: COMPLETED